vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $18.9M, roughly 1.8× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -1.8%, a 16.4% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs -3.2%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $-2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
CLFD vs ELMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $18.9M |
| Net Profit | $-614.0K | $2.8M |
| Gross Margin | 33.2% | 78.4% |
| Operating Margin | -5.3% | 19.2% |
| Net Margin | -1.8% | 14.6% |
| Revenue YoY | -3.2% | 16.3% |
| Net Profit YoY | 67.8% | 40.3% |
| EPS (diluted) | $-0.04 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $18.9M | ||
| Q3 25 | $23.4M | $16.9M | ||
| Q2 25 | $49.9M | $17.4M | ||
| Q1 25 | $47.2M | $15.7M | ||
| Q4 24 | $29.7M | $16.3M | ||
| Q3 24 | $5.6M | $14.7M | ||
| Q2 24 | $48.8M | $14.8M | ||
| Q1 24 | $36.9M | $13.9M |
| Q4 25 | $-614.0K | $2.8M | ||
| Q3 25 | $-9.1M | $2.1M | ||
| Q2 25 | $1.6M | $2.2M | ||
| Q1 25 | $1.3M | $1.9M | ||
| Q4 24 | $-1.9M | $2.0M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $-447.0K | $1.8M | ||
| Q1 24 | $-5.9M | $1.5M |
| Q4 25 | 33.2% | 78.4% | ||
| Q3 25 | 53.2% | 78.1% | ||
| Q2 25 | 30.5% | 78.3% | ||
| Q1 25 | 30.1% | 78.0% | ||
| Q4 24 | 29.2% | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | 21.9% | 76.2% | ||
| Q1 24 | 7.7% | 74.8% |
| Q4 25 | -5.3% | 19.2% | ||
| Q3 25 | 10.3% | 15.8% | ||
| Q2 25 | 3.0% | 17.5% | ||
| Q1 25 | 0.6% | 13.6% | ||
| Q4 24 | -6.9% | 15.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | -4.7% | 15.7% | ||
| Q1 24 | -26.4% | 13.3% |
| Q4 25 | -1.8% | 14.6% | ||
| Q3 25 | -38.8% | 12.6% | ||
| Q2 25 | 3.2% | 12.7% | ||
| Q1 25 | 2.8% | 12.1% | ||
| Q4 24 | -6.4% | 12.1% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | -0.9% | 12.3% | ||
| Q1 24 | -16.0% | 10.8% |
| Q4 25 | $-0.04 | $0.32 | ||
| Q3 25 | $-0.65 | $0.25 | ||
| Q2 25 | $0.11 | $0.26 | ||
| Q1 25 | $0.09 | $0.21 | ||
| Q4 24 | $-0.13 | $0.22 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | $-0.04 | $0.20 | ||
| Q1 24 | $-0.40 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $45.4M |
| Total Assets | $268.1M | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $13.8M | ||
| Q3 25 | $106.0M | $14.1M | ||
| Q2 25 | $117.2M | $15.3M | ||
| Q1 25 | $112.0M | $15.2M | ||
| Q4 24 | $113.0M | $16.2M | ||
| Q3 24 | $129.0M | $13.9M | ||
| Q2 24 | $123.8M | $16.1M | ||
| Q1 24 | $142.9M | $11.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $45.4M | ||
| Q3 25 | $256.2M | $44.7M | ||
| Q2 25 | $264.5M | $43.2M | ||
| Q1 25 | $265.9M | $43.9M | ||
| Q4 24 | $267.4M | $43.6M | ||
| Q3 24 | $275.8M | $41.5M | ||
| Q2 24 | $274.6M | $44.5M | ||
| Q1 24 | $279.2M | $42.5M |
| Q4 25 | $268.1M | $54.9M | ||
| Q3 25 | $306.2M | $53.6M | ||
| Q2 25 | $314.7M | $53.8M | ||
| Q1 25 | $310.9M | $52.5M | ||
| Q4 24 | $303.2M | $52.3M | ||
| Q3 24 | $315.3M | $48.9M | ||
| Q2 24 | $318.1M | $52.2M | ||
| Q1 24 | $315.4M | $48.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $3.0M |
| Free Cash FlowOCF − Capex | $-2.4M | $2.4M |
| FCF MarginFCF / Revenue | -7.1% | 12.7% |
| Capex IntensityCapex / Revenue | 2.9% | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $3.0M | ||
| Q3 25 | — | $169.0K | ||
| Q2 25 | $7.9M | $3.9M | ||
| Q1 25 | $3.0M | $2.1M | ||
| Q4 24 | $7.2M | $3.2M | ||
| Q3 24 | $22.2M | $2.3M | ||
| Q2 24 | $4.0M | $4.5M | ||
| Q1 24 | $-5.7M | $1.4M |
| Q4 25 | $-2.4M | $2.4M | ||
| Q3 25 | — | $-83.0K | ||
| Q2 25 | $7.5M | $3.7M | ||
| Q1 25 | $654.0K | $1.9M | ||
| Q4 24 | $5.1M | $2.9M | ||
| Q3 24 | $18.2M | $2.3M | ||
| Q2 24 | $2.8M | $4.5M | ||
| Q1 24 | $-7.7M | $1.3M |
| Q4 25 | -7.1% | 12.7% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | 15.1% | 21.4% | ||
| Q1 25 | 1.4% | 12.2% | ||
| Q4 24 | 17.1% | 18.0% | ||
| Q3 24 | 323.0% | 15.5% | ||
| Q2 24 | 5.8% | 30.1% | ||
| Q1 24 | -20.8% | 9.1% |
| Q4 25 | 2.9% | 3.4% | ||
| Q3 25 | 2.0% | 1.5% | ||
| Q2 25 | 0.8% | 0.8% | ||
| Q1 25 | 5.1% | 1.0% | ||
| Q4 24 | 7.0% | 1.4% | ||
| Q3 24 | 71.4% | 0.3% | ||
| Q2 24 | 2.5% | 0.1% | ||
| Q1 24 | 5.3% | 0.6% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | 4.93× | 1.75× | ||
| Q1 25 | 2.30× | 1.10× | ||
| Q4 24 | — | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
